Skip to content

effect of vitamin D on glycated hemoglobin A1 in patients with uncontrolled type 2 diabetes with vitamin D deficiency.

survey effect of vitamin D on glycated hemoglobin A1 in patients with uncontrolled type 2 diabetes with vitamin D deficiency.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013072414143N1
Enrollment
96
Registered
2013-08-15
Start date
2013-03-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Intervention group 1:4 ampules vitamin D3,2 ampules loading dose,1 ampule in 2th month,1 ampule in 4th month intramuscular.each ampule contain 300000 unit vitamin D.routine treatment o
Treatment - Drugs
Intervention group 1:4 ampules vitamin D3,2 ampules loading dose,1 ampule in 2th month,1 ampule in 4th month intramuscular.each ampule contain 300000 unit vitamin D.routine treatment of diabetes is ad
Intervention group 1 :routine treatment of diabetes is administered only.

Sponsors

For research ,kermanshah university of medical science vice chancellor
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who are receiving vitamin D supplement or who received it in late or have chronic liver disease or chronic renal failure(GFR<30ml/min)or have diseases related vitamin D or have malabsorption remote from study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Hemoglubin A1c. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.

Secondary

MeasureTime frame
Fasting plasma glucose. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;Triglyceride. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;Total cholestrol. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;High density cholestrol. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.;Low density cholestrol. Timepoint: Before,4 and 6 month after trial. Method of measurement: Lab data.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr karoon shahebrahimi

Imam reza hospita

Kshahebrahimi@ gmail .com+98 83 1836 2014

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026